Inebilizumab

Inebilizumab, sold under the brand name Uplizna, is a medication for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults.[2][3][1] The most common adverse reactions include urinary tract infection, headache, joint pain (arthralgia), nausea and back pain.[2][1] Inebilizumab is a humanized mAb that binds to and depletes CD19+ B cells including plasmablasts and plasma cells.[1] T... [wikipedia]